PSEN1 and Alzheimer disease: In the present study, we found that upregulation of xCT expression in APP/PS1 AD mice was restored after Cef treatment, which means that the xCT expression in Cef-treated APP/PS1 AD mice was downregulated, rather than upregulated, compared with no Cef-treated APP/PS1 AD mice.